US4050241003
US4050241003
Haemonetics Corporation
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 1.334.027.000 | 1.360.824.000 | 2.0% |
| Cost of Revenue | 546.441.000 | 611.866.000 | 10.7% |
| Gross Profit | 787.586.000 | 748.958.000 | 5.2% |
| 546.185.000 | 547.772.000 | 0.3% | |
| Operating Income | 241.401.000 | 201.186.000 | 20.0% |
| Pretax Income | 128.030.000 | 212.071.000 | 39.6% |
| Net Income Common Stockholders | 97.308.000 | 167.679.000 | 42.0% |
| -- | -- | -- | |
| -- | -- | -- |